跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
XENPOZYME 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
XENPOZYME 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Sanofi B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 29, 2022
Approval ID
d6c44ec002e1f509
Company
Sanofi B.V.
Type
Standard
Approval Details
Approval Id
d6c44ec002e1f509
Drug Cima Aemps Name
XENPOZYME 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1221659001
Holder Company Name
Sanofi B.V.
Marketing Company Name
Sanofi Aventis S.A.
Holder Company Detail Path
/organization/sanofi-b-v
Authorization Date
2022-07-29
Dosage Form
POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
20 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Sanofi B.V.
Company Detail Path
/organization/sanofi-b-v
Company Information
Pharmaceutical Company Name
Sanofi B.V.
Country Name
Netherlands
City Name
amsterdam,noord-holland,country_nl
Address
Paasheuvelweg 25
Active Ingredients
OLIPUDASA ALFA
20 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 29, 2022
Approval ID
d6c44ec002e1f509
Type
Standard
Back to CIMA-AEMPS Approvals
XENPOZYME 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
